搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Cyanothece sp. Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP484025DZZ
CSB-EP484025DZZ
CSB-BP484025DZZ
CSB-MP484025DZZ
CSB-EP484025DZZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanothece sp. Maf-like protein PCC7424_1128 (PCC7424_1128) CSB-YP484026DZZ
CSB-EP484026DZZ
CSB-BP484026DZZ
CSB-MP484026DZZ
CSB-EP484026DZZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanothece sp. ATP synthase gamma chain (atpG) CSB-YP484027DZZ
CSB-EP484027DZZ
CSB-BP484027DZZ
CSB-MP484027DZZ
CSB-EP484027DZZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanothece sp. Photosystem I assembly protein ycf3 (ycf3) CSB-YP484028DZZ
CSB-EP484028DZZ
CSB-BP484028DZZ
CSB-MP484028DZZ
CSB-EP484028DZZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanothece sp. Phosphoglucosamine mutase (glmM) CSB-YP484029DZZ
CSB-EP484029DZZ
CSB-BP484029DZZ
CSB-MP484029DZZ
CSB-EP484029DZZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum Aspartate--tRNA ligase (aspS), partial CSB-YP484030MSY
CSB-EP484030MSY
CSB-BP484030MSY
CSB-MP484030MSY
CSB-EP484030MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum Formamidopyrimidine-DNA glycosylase (mutM) CSB-YP484031MSY
CSB-EP484031MSY
CSB-BP484031MSY
CSB-MP484031MSY
CSB-EP484031MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (gpmA) CSB-YP484032MSY
CSB-EP484032MSY
CSB-BP484032MSY
CSB-MP484032MSY
CSB-EP484032MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum 30S ribosomal protein S9 (rpsI) CSB-YP484033MSY
CSB-EP484033MSY
CSB-BP484033MSY
CSB-MP484033MSY
CSB-EP484033MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum 7-cyano-7-deazaguanine synthase (queC) CSB-YP484034MSY
CSB-EP484034MSY
CSB-BP484034MSY
CSB-MP484034MSY
CSB-EP484034MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum Protein hfq (hfq) CSB-YP484035MSY
CSB-EP484035MSY
CSB-BP484035MSY
CSB-MP484035MSY
CSB-EP484035MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum Tryptophan synthase alpha chain (trpA) CSB-YP484036MSY
CSB-EP484036MSY
CSB-BP484036MSY
CSB-MP484036MSY
CSB-EP484036MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum Chorismate synthase (aroC) CSB-YP484037MSY
CSB-EP484037MSY
CSB-BP484037MSY
CSB-MP484037MSY
CSB-EP484037MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum DNA ligase (ligA), partial CSB-YP484038MSY
CSB-EP484038MSY
CSB-BP484038MSY
CSB-MP484038MSY
CSB-EP484038MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum Transcriptional repressor NrdR (nrdR) CSB-YP484039MSY
CSB-EP484039MSY
CSB-BP484039MSY
CSB-MP484039MSY
CSB-EP484039MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum 30S ribosomal protein S4 (rpsD) CSB-YP484040MSY
CSB-EP484040MSY
CSB-BP484040MSY
CSB-MP484040MSY
CSB-EP484040MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum FMN reductase (NADH) RutF 1 CSB-YP484041MSY
CSB-EP484041MSY
CSB-BP484041MSY
CSB-MP484041MSY
CSB-EP484041MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum Alkanesulfonate monooxygenase (ssuD) CSB-YP484042MSY
CSB-EP484042MSY
CSB-BP484042MSY
CSB-MP484042MSY
CSB-EP484042MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum Integration host factor subunit alpha (ihfA) CSB-YP484043MSY
CSB-EP484043MSY
CSB-BP484043MSY
CSB-MP484043MSY
CSB-EP484043MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum Ribosome maturation factor RimM (rimM) CSB-YP484044MSY
CSB-EP484044MSY
CSB-BP484044MSY
CSB-MP484044MSY
CSB-EP484044MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>